bioRxiv · 10.64898/2026.01.30.702936
Ketone body beta-hydroxybutyrate restores neuronal Tau proteostasis via ketolysis-independent mechanism
Abstract
Metabolic interventions that induce ketosis, including ketogenic diets, caloric restriction, intermittent fasting, and exercise, show promise in the treatment of Alzheimers disease (AD) and related tauopathies. {beta}-hydroxybutyrate ({beta}HB), the primary ketone body produced during ketosis, reproduces key features of these metabolic interventions, but the molecular mechanism underlying its neuroprotective properties is not fully understood. Here, we demonstrate that a {beta}HB precursor diet is sufficient to ameliorate Tau pathophysiology in a tauopathy mouse model. Furthermore, across in vitro, ex vivo, and in vivo models, we find that {beta}HB enhances neuronal Tau proteostasis and reduces Tau aggregation and secretion. Importantly, these effects are independent of {beta}HBs oxidation for ATP production, as its ketolysis-resistant enantiomer reproduces these benefits, indicating that ketolysis is dispensable for these effects. Overall, these data position {beta}HB as a novel therapeutic avenue for AD and tauopathy and elucidate a novel mechanism of action of metabolic interventions in neurodegenerative disease.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Rossitto, L.-A. M., Foo, J., Di Silvestri, J. M., Lehmann, L., Brunelli, M., Nie, Y., Munoz-Mayorga, D., Xiao, Q., Dai-Liu, A. Y., Jati, S., Rossi, M., Daneman, R., Kelly, J. W., Newman, J. C., Myers, S. A., Chen, X.. 2026-02-02. Ketone body beta-hydroxybutyrate restores neuronal Tau proteostasis via ketolysis-independent mechanism. https://doi.org/10.64898/2026.01.30.702936
Cite the original work for its findings. Save a collection to share your selection of sources.